Don’t Miss Out! 3 Top-Tier Blue-Chip Growth Stocks for Your Must-Buy List

investorplace.com For investors looking for blue-chip growth stocks to own, here's a great place to start Blue-chip growth stocks are all around us. Yet, finding the right fit for your…

Sanders launches investigation into ‘unacceptable’ diabetes, weight loss drug prices

thehill.com Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday launched an investigation into the “outrageously high…

Senate Committee Investigates Ozempic and Wegovy Costs

nytimes.com A Senate committee is investigating the prices that Novo Nordisk charges for its blockbuster medications, Ozempic and Wegovy, which are highly effective at treating diabetes…

What's Going On With Novo Nordisk Stock Today?

benzinga.com The Senate Committee on Health, Education, Labor, and Pensions is reportedly scrutinizing Novo Nordisk A/S NVO ‘s pricing strategies, particularly those of its diabetes and…

How Ozempic Is Transforming a Small Danish Town

nytimes.com As the sun sets over the harbor in Kalundborg, a small town about 60 miles west of Copenhagen, light streams through the glass walls of Shaun Gamble’s cafe and bathes his…

It Introduced Ozempic to the World. Now It Must Remake Itself

nytimes.com Lars Fruergaard Jorgensen has a problem: Too many people want what he’s selling. Mr. Jorgensen is the chief executive of Novo Nordisk, the Danish drugmaker. Even if the…

Utah mom fights for her daughter’s access to discontinued diabetes medication: ‘Life-saving'

foxnews.com A Utah mother is fighting for her access to diabetes medicine. Ruby Smart, 15, has been taking Levemir (detemir) insulin since she was diagnosed with more than two years…

German Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline

benzinga.com Thursday, Germany’s competition authority, Bundeskartellamt, cleared the planned acquisition of Cardior Pharmaceuticals GmbH by Danish pharma giant Novo Nordisk A/S NVO.…

Zepbound weight loss drug shortage has no immediate end in sight, Eli Lilly says

nbcnews.com Create your free profile or log in to save this article Create your free profile or log in to save this article Despite Eli Lilly’s assurances about an ample supply of its…

The Newest Obesity Drug May Also Combat Sleep Apnea

gizmodo.com The newest weight loss drug on the market, Zepbound, might also help keep people’s snoring down. On Wednesday, Eli Lilly announced the preliminary results of two Phase III…

3 Weight-Loss ETFs to Profit From the Obesity Drug Boom

investorplace.com Explore weight-loss ETFs for a direct route into the booming sector spurred by celebrity influence People are interested in ETFs for weight loss because of Oprah’s TV show…

Ozempic isn't linked to suicidal thoughts, U.S. and European health agencies find

nbcnews.com Health agencies in the U.S. and Europe say there’s no evidence that thoughts of suicide or self-harm are linked to the popular weight loss and diabetes drug semaglutide,…

Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027

investorplace.com Weight-loss stocks are in, and these three companies could be big winners in this space Weight-loss stocks remain the focus of many investors. The GLP-1 drugs that many…